Filed Under: Analysts Price Targets • Market News Investment analysts at Leerink Swann hoisted their target price on shares of Akorn (NASDAQ:AKRX) from $42.00 to $55.00 in a note issued to investors on Friday. The firm currently has a market ...American Banking News - Forex, 2 hours ago Wageworks Price Target Increased to $70.00 by Analysts at Leerink Swann (WAGE) American Banking News, 2 weeks ago Wright Medical Group Given New $31.00 Price Target at Leerink Swann (WMGI) American Banking News, 3 weeks ago Stryker PT Raised to $105.00 at Needham & Company LLC (NYSE:SYK) American Banking News, 1 month ago
Equities researchers at Leerink Swann assumed coverage on shares of CONMED (NASDAQ:CNMD) in a research report issued on Friday, TheFlyOnTheWall.com reports. The firm set an outperform rating and a $60.00 price target on the stock. Leerink Swann's ...SleekMoney, 1 week ago CONMED Receives New Coverage from Analysts at Leerink Swann (CNMD) American Banking News, 2 weeks ago
Statement from Phillip Blake, President of Bayer Corporation, on FDA Commissioner Margaret Hamburg, M.D.
(Date:2/5/2015)... BOULDER, Colo. , Feb. 5, 2015 ... ARRY ) today announced that its Chief ... present at the Leerink Swann Healthcare Conference ... to participate in the conference through a ... Healthcare Conference Presenter:Ron Squarer, Chief ...Bio-Medicine, 3 weeks ago
Filed Under: Analysts Downgrades • Market News Akorn (NASDAQ:AKRX?) was downgraded by investment analysts at Needham & Company LLC to a hold rating in a note issued to investors on Friday. A number of other firms have also recently commented ...American Banking News, 15 hours ago Stock Analysts Downgrades for February, 27th (AKRX, ANSS, BBG, BOY, CA, CBOE, CLMS, CNNX, CPI, CR) American Banking News, 1 day ago Akorn Upgraded by TheStreet to Buy (AKRX) American Banking News, 13 hours ago Stryker Downgraded to Neutral at JPMorgan Chase & Co. American Banking News, 1 month ago
Insider Selling: Everyday Health major shareholder Revolution Wf Holdings Llc Sells 367,380 Shares of Stock (EVDY)
Everyday Health (NASDAQ:EVDY) major shareholder Revolution Wf Holdings Llc sold 367,380 shares of the company's stock in a transaction that occurred on Tuesday, December 30th. The shares were sold at an average price of $14.59, for a total ...SleekMoney, 1 month ago Insider Selling: Sophiris Bio major shareholder Sells 881,479 Shares of Stock (SPHS) SleekMoney, 2 months ago
InVitae Corporation (formerly Locus Development, Inc.), a US-based genetic diagnostics company, has completed its initial public offering (IPO) of 7,302,500 shares of common stock, including the over-allotment option of 952,500 shares of common ...Individual.com, 1 week ago
Source: Exelixis What's Happening: Exelixis 's shares are surging higher by more than 13% ahead of the company's scheduled presentation at the Leerink Swann Global Healthcare Conference on Wednesday February 11th, at 11:30 am. Why It's Happening: ...Nasdaq, 2 weeks ago
Several brokerages have updated their recommendations and price targets on shares of Stryker (NYSE: SYK) in the last few weeks: 1/27/2015 Stryker had its price target raised by analysts at Credit Suisse from $90.00 to $100.00. They now have an ...WKRB News, 1 month ago Investment Analysts Recent Ratings Updates for Stryker (SYK) Mideast Time, 1 month ago Brean Capital Reiterates Hold Rating for Stryker American Banking News - Forex, 1 month ago Stryker Earns AA Credit Rating from Morningstar (SYK) American Banking News, 2 months ago
Bristol-Myers Squibb Co (BMY) Q4 Earnings Preview: Expect Earnings And Revenue To Continue Declining
Bristol-Myers Squibb Co ( NYSE:BMY ) is set to announce its financials for the fourth quarter of fiscal year 2014 before the market opens for trading today. The drug-maker is expected to report earnings of $0.4 per share for the quarter, a 20.8% ...Bidness Etc, 1 month ago Bristol-Myers Squibb Co Lung Cancer Drug Successful In Late-Stage Trial Bidness Etc, 1 month ago
on your WebpageAdd Widget >Get your members hooked!